Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: A double-blind placebo-controlled study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 5, 2004, Pages 498-504

  Bufe, A ^a,b   Ziegler Kirbach, E ^a,b   Stoeckmann, E ^a,b   Heidemann, P ^a   Gehlhar, K ^a   Holland Letz, T ^a   Braun, W ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Allergy; Asthma; Children; Grass pollen; IgE; IgG; IgG4; Immunotherapy; SLIT

Indexed keywords

GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PLACEBO; SUBLIVAC;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ANAPHYLAXIS; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; GRASS POLLEN; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INTERVIEW; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT COMPLIANCE; POLLEN ALLERGY; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RHINOCONJUNCTIVITIS; SCORING SYSTEM; SIDE EFFECT; SKIN SENSITIVITY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME; URTICARIA;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANTIBODIES; CHILD; CONJUNCTIVITIS, ALLERGIC; DEGLUTITION; DOUBLE-BLIND METHOD; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; PLACEBOS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; TREATMENT OUTCOME;

EID: 2342534414     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00457.x     Document Type: Article

References (17)

1. BOUSQUET J, LOCKEY RF, MALLING HJ. WHO Position Paper; Allergen immunotherapy: therapeutic vaccines for allergic diseases. J Allergy Clin Immunol 1998;102:558-562.
2. MALLING HJ, ABREU-NOGUEIRA J, ALVAREZ-CUESTA E, BJÖRKSTEN B, BOUSQUET J, CAILLOT D et al. Position paper: local immunotherapy. Allergy 1998;53:933-944.
3. BUFE A, GEHLHAR K, SCHRAMM G, SCHLAAK M, BECKER W-M. Allergenic activity of a major pollen allergen is elevated in the presence of nasal secretion. Am J Respir Crit Care Med 1998;157:1269-1276.
4. BAGNASCO M, MARIANI G, PASSALACQUA G, MOTTA C, BARTOLOMEI M, FALAGIANI P et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by non-injectable routes in healthy human beings. J Allergy Clin Immunol 1997;100:122-129.
5. PASSALACQUA G, ALBANO M, FREGONESE L, RICCIO A, PRONZATO C, MELA GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis [see comments]. Lancet 1998;351:629-632.
6. CLAVEL R, BOUSQUET J, ANDRE C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493-498.
7. GEHLHAR K, SCHLAAK M, BECKER W-M, BUFE A. Monitoring specific immunotherapy of pollen allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy 1999;29:497-506.
8. BOUSQUET J, SCHEINMANN P, GUINNEPAIN MT, PERRIN-FAYOLLE M, SAUVAGET J, TONNEL AB et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249-260.
9. DREBORG S. Skin-prick test. Allergy 1985;40:55-59.
10. BUFE A, BECKER W-M, SCHRAMM G, PETERSEN A, MAMAT U, SCHLAAK M. Major allergen Ph1 p Va (timothy grass) bears at least two different IgE-reactive epitopes. J Allergy Clin Immunol 1994;94:173-181.
11. PAJNO GB, MORABITO L, BARBERIO G, PARMIANI S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study 64. Allergy 2000;55:842-849.
12. LA ROSA M, RANNO C, ANDRE C, CARAT F, TOSCA MA, CANONICA G. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-432.
13. MALLING HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-472.
14. GIOVANE AL, BARDARE M, PASSALACQUA G, RUFFONI S, SCORDAMAGLIA A, GHEZZI E et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 1994;24:53-59.
15. PASSALACQUA G, ALBANO M, RICCIO AM, SCORDAMAGLIA A, CANONICA GW. Local nasal immunotherapy: experimental evidences and general considerations. Allergy 1997;52:10-16.
16. BATARD T, WEYER A, LAROZE A, ICKOVIC M-R, DAVID B, PELTRE G et al. Isotypic analysis of grass pollen-specific antibodies in human plasma. 4. Biological activity of allergen-specific and autoanti-IgE antibody fractions on basophil histamine release. Clin Exp Allergy 1996;26:1308-1315.
17. DAERON M, MALBEC O, LATOUR S, AROCK M, FRIDMAN WH. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995;95:577-585.